Table 1 General characteristics of PDAC patients analyzed (N = 135)
From: Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
Characteristic | Mean (Std.)/Median | Count (%) |
|---|---|---|
Age (yrs) | 65.56 (10.91) | - |
Survival length (days) | 214 | - |
Baseline LDH (U/L) | 216.04 (90.96) | - |
Baseline albumin (g/L) | 38.61 (5.09) | - |
Sex (Male) | - | 65 (48.15) |
Subsequent chemotherapy (Yes) | - | 68 (50.37) |
Gemcitabine only | - | 12 (17.65) |
Gemcitabine combined chemotherapy | - | 50 (73.53) |
Other chemotherapy regimen | - | 6 (8.82) |